Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNDANCE: Sunitinib Maintenance After SRS for Brain Metastases
NCT00910039Phase 2Terminated
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Apr 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in brain metastases, sponsored by Case Comprehensive Cancer Center. Started Apr 2009; status: terminated.
02
Drugs
sunitinib
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00910039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910039.